Related Experiment Video
Updated: Aug 30, 2025
10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.2K
Polish Consensus on Gastric Cancer Diagnosis and Treatment - Update 2022
Piotr Richter1, Grzegorz Wallner2, Wojciech Zegarski3
1First Department of General Surgery, Jagiellonian University, Collegium Medicum, Cracow, Poland.
Polski Przeglad Chirurgiczny
|September 1, 2022
Summary
This updated 2022 consensus provides expert guidance on gastric cancer diagnosis and treatment. It reflects a year of work by Polish specialists, finalized for publication.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Gastric cancer remains a significant health concern globally and in Poland.
- Previous consensus guidelines required updating to incorporate recent advancements.
- Expert consensus is crucial for standardizing care and improving patient outcomes.
Purpose of the Study:
- To present the "Polish Consensus on Gastric Cancer Diagnosis and Treatment - Update 2022".
- To consolidate expert opinions and recent evidence into actionable clinical guidelines.
- To provide a unified approach for Polish specialists in managing gastric cancer.
Main Methods:
- Expert consensus development through dedicated specialist collaboration throughout 2021.
- Review and synthesis of current scientific literature and clinical practices.
- Finalization of recommendations following a conference in December 2021.
Main Results:
- The consensus document offers updated recommendations for gastric cancer diagnosis.
- It provides current treatment strategies for gastric cancer.
- The guidelines are effective from June 14th, 2022.
Conclusions:
- The "Polish Consensus on Gastric Cancer Diagnosis and Treatment - Update 2022" offers a vital resource for clinicians.
- Adherence to these updated guidelines aims to improve the standard of care for gastric cancer patients in Poland.
- This consensus underscores the collaborative efforts of the Polish Society of Surgical Oncology and the Association of Polish Surgeons.
Related Concept Videos
01:21Barrett Esophagus-II: Clinical Manifestations and Management
282
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
282
01:23Gastritis III: Clinical Manifestations and Management
422
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
422
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
188
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
188
01:29Chronic Pancreatitis II: Collaborative Care
123
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
123
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K